Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 50016497
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595346(CHEMBL5189108)
Affinity DataIC50: 0.810nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595349(CHEMBL5202756)
Affinity DataIC50: 0.820nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595352(CHEMBL5175180)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595350(CHEMBL5182597)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595353(CHEMBL5179372)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595351(CHEMBL5200092)
Affinity DataIC50: 3.20nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595345(CHEMBL5182234)
Affinity DataIC50: 5.60nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595337(CHEMBL5195621)
Affinity DataIC50: 5.90nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595346(CHEMBL5189108)
Affinity DataIC50: 7.40nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595348(CHEMBL5170585)
Affinity DataIC50: 7.70nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595342(CHEMBL5170208)
Affinity DataIC50: 7.90nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595349(CHEMBL5202756)
Affinity DataIC50: 13nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595347(CHEMBL5169835)
Affinity DataIC50: 14nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595352(CHEMBL5175180)
Affinity DataIC50: 20nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595341(CHEMBL5202535)
Affinity DataIC50: 23nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595353(CHEMBL5179372)
Affinity DataIC50: 26nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595340(CHEMBL5173692)
Affinity DataIC50: 30nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595350(CHEMBL5182597)
Affinity DataIC50: 32nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595344(CHEMBL5182789)
Affinity DataIC50: 54nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595345(CHEMBL5182234)
Affinity DataIC50: 57nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595351(CHEMBL5200092)
Affinity DataIC50: 65nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595348(CHEMBL5170585)
Affinity DataIC50: 84nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595337(CHEMBL5195621)
Affinity DataIC50: 94nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595342(CHEMBL5170208)
Affinity DataIC50: 120nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595338(CHEMBL5190122)
Affinity DataIC50: 140nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595347(CHEMBL5169835)
Affinity DataIC50: 180nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595341(CHEMBL5202535)
Affinity DataIC50: 310nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595339(CHEMBL5205880)
Affinity DataIC50: 400nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595340(CHEMBL5173692)
Affinity DataIC50: 540nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595343(CHEMBL5188778)
Affinity DataIC50: 680nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on steady state using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly-Lys...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595344(CHEMBL5182789)
Affinity DataIC50: 940nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595338(CHEMBL5190122)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595343(CHEMBL5188778)
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetEnteropeptidase(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50595339(CHEMBL5205880)
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of human recombinant Enteropeptidase assessed as inhibition based on initial velocity using 5FAM-Abu-Gly-Asp -Asp-Asp -Lys-Ile-Val-Gly-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed